Rewriting Life Gene therapy could free some people from a lifetime of blood transfusions Correcting a genetic mutation lets beta thalassemia patients make healthy blood cells. by Emily Mullin 2018-04-18T17:18:00-04:00
Rewriting Life When curing a disease with gene therapy is bad business A drug giant turns over its pipeline of miracle drugs to a startup. by Antonio Regalado 2018-04-12T15:24:00-04:00
Rewriting Life CRISPR trials are about to begin in people—but we still don’t know how well it works in monkeys Monkey studies look encouraging but show there’s still a lot to learn about the gene-editing technology. by Emily Mullin 2018-04-11T07:00:00-04:00
Rewriting Life This company can encode your favorite song in DNA—for $100,000 It’s not cheap. But Twist Bioscience thinks storing data in genes could be the next big thing. by Bryan Walsh 2018-04-06T09:58:00-04:00
Rewriting Life CRISPR may not cause hundreds of rogue mutations after all Researchers behind a controversial paper have admitted that their results may be wrong. by Emily Mullin 2018-03-30T16:41:00-04:00
Rewriting Life Genes of human “mutants” point to a new superpower DNA search finds people resistant to liver disease. Can we mimic the effect with a drug? by Antonio Regalado 2018-03-21T17:00:00-04:00
Rewriting Life Farmland gene editors want cows without horns, pigs without tails, and business without regulations The lobbying effort to get the FDA out of the way of biotech animals is under way. by Antonio Regalado 2018-03-12T11:16:00-04:00
Rewriting Life In the future we won’t edit genomes—we’ll just print out new ones Why redesigning the humble yeast could kick off the next industrial revolution. by Bryan Walsh 2018-02-16T00:00:00-05:00
Rewriting Life Gene-altering treatments are medicine’s best shot yet against Huntington’s disease After 25 years, scientists are starting to make progress against the devastating illness. by Emily Mullin 2018-02-15T15:02:00-05:00
Rewriting Life Biologists would love to program cells as if they were computer chips A startup is selling “circuits” for making drugs and chemicals inside bacteria. by Monique Brouillette 2018-02-13T12:09:00-05:00
